Response to Comments: MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer (BCI) Gene Expression Test (DL37921)

The provided policy record (A56336) contains only a title and no substantive policy text, so covered indications, limitations, documentation requirements, and frequency limits for the Inivata/InVisionFirst liquid biopsy and BCI gene expression test cannot be determined from this input. Manual review of the full policy document (DL37921) is required to extract actionable coverage criteria and associated ICD-10, age, and body-part tags.

"No policy content provided; unable to extract covered indications for the Inivata/InVisionFirst liquid biopsy or BCI gene expression test for lung cancer."

Sign up to see full coverage criteria, indications, and limitations.